Cracking The Code: Understanding Repatha’s ICD-10 Classification

Repatha ICD 10 Code

Repatha is a medication that is used to lower LDL cholesterol levels in the blood. It is prescribed to patients who have high cholesterol levels that cannot be controlled through diet and exercise alone. The ICD 10 code for Repatha is Z79.899, which is used to indicate long term (current) use of other medications.

ICD Code History

The First Report of a Real-world Experience With a PCSK Inhibitor
The First Report of a Real-world Experience With a PCSK Inhibitor

The International Classification of Diseases (ICD) system has been used for over a century to classify and code diseases, conditions, and procedures. The ICD 10 code system was implemented in the United States in October 2015, replacing the previous ICD 9 system. The purpose of the ICD codes is to standardize the classification of diseases and medical procedures for billing and statistical purposes.

Synonyms

Dosing and Administration  Repatha® (evolocumab)
Dosing and Administration Repatha® (evolocumab)

Repatha is also known by its generic name, evolocumab. It belongs to a class of medications called PCSK9 inhibitors, which work by blocking a protein in the liver that helps regulate LDL cholesterol levels in the blood.

Clinical Information

Repatha is indicated for use in adults with primary hyperlipidemia or mixed dyslipidemia, as an adjunct to diet and other cholesterol-lowering therapies. It is also used to reduce the risk of heart attack, stroke, and coronary revascularization procedures in patients with established cardiovascular disease.

Causes, Symptoms, Diagnosis

High cholesterol levels can be caused by a variety of factors, including genetics, diet, and lifestyle choices. Symptoms of high cholesterol may not be noticeable until complications such as heart disease or stroke develop. Diagnosis of high cholesterol is typically made through a blood test that measures the levels of LDL and HDL cholesterol in the blood.

Treatment

Repatha is administered as a subcutaneous injection once every two weeks or once monthly, depending on the prescribed dosage. It should be used in conjunction with a healthy diet and exercise regimen to effectively lower LDL cholesterol levels. Regular monitoring of cholesterol levels and liver function tests is recommended while taking Repatha.

Conclusion

Repatha is a valuable medication for patients with high cholesterol levels that are not well-controlled with other treatments. By lowering LDL cholesterol levels, Repatha can reduce the risk of cardiovascular events and improve overall heart health. It is important for patients to work closely with their healthcare providers to determine the most appropriate treatment plan for their individual needs.

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button